Track the Marksans Pharma Limited stock price and the full insider trade history of the company, a listed equity based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Marksans Pharma Limited has recorded 13 insider filings. Market capitalisation: €117.1bn. The latest transaction was reported on 6 June 2024 (Purchase). Among the most active insiders: Arvind Singh. All data is openly available.
13
Insider Decl.
n/a
Thresholds
€1m
7 ops.
Buy Volume
€31,575
6 ops.
Sell Volume
10Σ signal
Buys €1m€31,575 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,527 of 29,065 companies
61.8
score / 100
Value
46
Quality
77
FCF yld2.8%
Earn yld3.6%
EV/EBITDA17.6x
ROE15%
Gross mgn57%
Net mgn14%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.